Research labs - Institute of Art and Technology
The Institute of Art and Technology focuses on the following themes: contemporary art, 3D digital art, the uses of art, exhibitions and curatorship, as well as design discourse and practice.
The Institute of Art and Technology focuses on the following themes: contemporary art, 3D digital art, the uses of art, exhibitions and curatorship, as well as design discourse and practice.
The Contemporary Art Lab's digital creative research relates to the relationship between technology and culture, as well as the way meaning unfolds through new computational forms.
Read more about the Experimental Technologies Lab, an enhancement upon four years of research pursued at our pioneering workshop and research space, FACTLab, a collaboration with Liverpool’s FACT, the Foundation for Art and Creative Technologies, the UK’s leading new technologies arts organisation.
The Uses of Art Lab, based within ART LABS, asks how we can use art more effectively in society. Discover the themes and projects based within the Lab.
The Exhibition Research Lab is the first centre devoted to the study of exhibitions. We have ties with Tate Liverpool, the Liverpool Biennial, as well as six major European museums and a network of arts institutions. Find out more about the Lab's collaborations and projects.
Every year, researchers from ART LABS publish over 50 publications. Staff create publications within a number of key disciplines, including: contemporary art, 3D digital art, the uses of art and cultural enrichment, exhibitions and curatorship, as well as design discourse and practice.
Members of staff from the Institute of Art and Technology are experts within the fields of art, design and technology.
Academics at the Institute of Art and Technology undertake a variety of high-impact projects that relate to the Centre’s core research themes.
Watch Professor of English Joe Moran speak about shyness as a condition “ignored” in the current wave of attention on mental health and wellbeing.
Find out more about how LJMU Business School created a model that re-engineers the relationship between pharmaceutical companies and trials operator, ensuring greater communication and common purpose. Improving patient outcomes through better project management of clinical trials